3i Infotech sells billing and payments unit for USD 137 mn

Rs 617 crore deal to strengthens the balance sheet of 3i Infotech

PTI | May 16, 2011



Global information technology company 3i Infotech Limited has signed an agreement to sell its US-based Global Billing and Payments unit, consisting of Regulus Group and J&B Software, to an affiliate of Cerberus Capital Management LP for USD 137 million (Rs 617 crore).

3i Infotech acquired J&B Software in 2007 and Regulus Group in 2008, and the companies were integrated to form the Global Billing & Payments unit of 3i Infotech, according to a company statement.

The transaction is expected to close within the next 60 days, subject to customary closing conditions and any regulatory approvals.

"The divestment reduces the leverage and strengthens the balance sheet of 3i Infotech," said 3i Infotech Managing Director & Global CEO V Srinivasan.

"This enables 3i Infotech to go back to its roots as a significant IT products and services player while at the same time allowing the billing and payments unit to be acquired by an organisation interested in growing it as an independent company."

Cerberus Managing Director and spokesperson Tim Price said: "Cerberus has the financial resources and operational expertise to help this business build additional value through operating efficiencies and growth. As a standalone entity, the company will continue to focus on delivering the best products and highest quality services to its clients."

"We are looking forward to partnering with Cerberus on the next stage of our company's growth," said Kathy Hamburger, the Chief Executive Officer and President of the US-based Global Billing and Payments division.

Cerberus Capital Management is a private investment firm with USD 23 billion of capital under management.

Shares of 3i Infotech were trading at Rs 50.35 in early trade on the BSE, up 0.70 per cent from the previous close.
 

Comments

 

Other News

How the mind can help the body heal itself

Why do some people recover from illness against all odds? Can our beliefs, emotions and consciousness influence the body’s ability to heal? Drawing on over three decades of experience in medicine, research and medical innovation, internationally trained ophthalmologist and author Dr Dinesh Verma ex

1,364 anti-cancer formulations to cost less from today

The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has capped trade margins on the Maximum Retail Price (MRP) of 137 anti-cancer drugs. This was based on the recommendations of an Expert Committee constitute

Who checks the books?

I read about the news about the Coimbatore library over coffee this morning. On the face of it, the headline was about a political ‘war’ between the DMK and TVK. But what stayed with me was something much more important than the blame game behind what had transpired. A writer walking through

Development paradox: Falling poverty miracle and an inequality problem

India’s reduction in poverty over the past decade is a development achievement of considerable significance. The World Bank’s April 2026 ‘India Development Update’ estimates that the share of Indians living below the international extreme-poverty line of $3.00 per person per day i

In Arunachal, a river we call mother

In Arunachal Pradesh, the Siang is not just a river. For many of us, especially the Adi people, it is part of our family. Our grandparents fished in it. Children learned to swim in it. Our farms drink from it. When someone says a huge dam will be built on it, we do not hear the word "project".

A new retelling of the Mahabharata delves into key moments

In a time when every decision carries consequences and questions of ambition, power, loyalty, identity and moral choice continue to shape our lives, Dr. Arun Krishnan’s new book, ‘Mahakshana’ (Penguin India) offers a strikingly relevant retelling of the Mahabharata.  

Upcoming Conferences



-->

Archives

Current Issue

Opinion

Facebook Twitter Google Plus Linkedin Subscribe Newsletter

Twitter